Weiling Medical Selected for the First Forbes China 100 Most Investable Startups List

Weiling Medical was selected for the "First Forbes China 100 Most Investable Startups" list, jointly launched by Forbes China and Westbund. The company focuses on full-stack R&D of medical-grade implantable wireless brain-computer interface technology, covering the entire chain from signal acquisition to transmission to decoding. In 2024, it launched China's first multicenter clinical study of fully implantable subdural flexible electrodes for brain-computer interfaces, covering more than ten tertiary hospitals nationwide. The Xili Lake International Science and Education City Proof-of-Concept Fund, managed by Leaguer Innovation, supported its development through equity investment in 2022.